Aflac (NYSE:AFL – Get Free Report) had its price target decreased by Piper Sandler from $122.00 to $118.00 in a report issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. Piper Sandler’s price objective would indicate a potential upside of 14.34% from the company’s previous close.
AFL has been the topic of several other reports. Bank of America raised their price objective on Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. BMO Capital Markets started coverage on Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective for the company. Truist Financial upped their price objective on shares of Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Barclays boosted their price target on shares of Aflac from $96.00 to $98.00 and gave the company an “underweight” rating in a report on Monday, January 6th. Finally, Wells Fargo & Company boosted their price objective on shares of Aflac from $103.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 14th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Aflac currently has an average rating of “Hold” and a consensus price target of $103.43.
Read Our Latest Stock Analysis on AFL
Aflac Trading Down 3.8 %
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 22.02% and a return on equity of 16.34%. Equities research analysts anticipate that Aflac will post 7.26 EPS for the current fiscal year.
Insider Buying and Selling
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.80% of the stock is currently owned by company insiders.
Institutional Trading of Aflac
A number of institutional investors have recently bought and sold shares of the business. AMF Tjanstepension AB increased its position in Aflac by 13.3% during the third quarter. AMF Tjanstepension AB now owns 252,137 shares of the financial services provider’s stock worth $28,206,000 after buying an additional 29,602 shares during the period. Dynamic Advisor Solutions LLC raised its position in Aflac by 3.7% in the 3rd quarter. Dynamic Advisor Solutions LLC now owns 4,373 shares of the financial services provider’s stock valued at $489,000 after purchasing an additional 157 shares during the last quarter. Wedmont Private Capital boosted its stake in Aflac by 5.3% during the 3rd quarter. Wedmont Private Capital now owns 7,000 shares of the financial services provider’s stock worth $783,000 after purchasing an additional 350 shares during the period. Beaumont Financial Advisors LLC grew its position in Aflac by 5.3% during the 3rd quarter. Beaumont Financial Advisors LLC now owns 3,683 shares of the financial services provider’s stock worth $412,000 after purchasing an additional 187 shares during the last quarter. Finally, Virginia Wealth Management Group Inc. increased its stake in Aflac by 27.3% in the third quarter. Virginia Wealth Management Group Inc. now owns 42,595 shares of the financial services provider’s stock valued at $4,762,000 after purchasing an additional 9,123 shares during the period. 67.44% of the stock is owned by hedge funds and other institutional investors.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
- Five stocks we like better than Aflac
- Bank Stocks – Best Bank Stocks to Invest In
- Why Amazon Could Be the Best Big Tech Investment of Q1
- Using the MarketBeat Stock Split Calculator
- Broadcom’s Bull Run: Time to Jump In?
- How to Profit From Growth Investing
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.